Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Lessened by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 169,770 shares of the medical equipment provider’s stock after selling 24,120 shares during the period. Manning & Napier Advisors LLC’s holdings in Intuitive Surgical were worth $88,613,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in ISRG. Bennett Selby Investments LP increased its position in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares during the period. LVW Advisors LLC increased its position in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares during the period. Wesbanco Bank Inc. increased its position in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares during the period. Hazlett Burt & Watson Inc. increased its position in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. increased its position in Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after acquiring an additional 20 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 28,749 shares of company stock valued at $15,303,875. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.5 %

Shares of Intuitive Surgical stock traded down $2.99 during midday trading on Wednesday, hitting $571.15. The company’s stock had a trading volume of 180,286 shares, compared to its average volume of 1,935,709. The firm has a market capitalization of $203.43 billion, a P/E ratio of 92.01, a PEG ratio of 5.19 and a beta of 1.39. The stock has a 50-day simple moving average of $548.70 and a 200-day simple moving average of $507.04. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analysts Set New Price Targets

Several analysts recently commented on the company. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Jefferies Financial Group lifted their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Royal Bank of Canada lifted their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.